Look for:

Products

KONINKLIJKE PHILIPS NV


ISIN:
NL0000009538
WKN:
0953
2021/05/05 16:53:05
Price
57.94 USD
Difference -0.10% (-0.06)

General attributes

ISINNL0000009538
SymbolPHIA
ExchangeFINRA other OTC Issues
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)43,220 EUR
BenchmarkAMSTERDAM EXCHANGES INDEX

Market data

Bid (Bid size)-
Ask (Ask size)-
Open57.94 USD
High57.94 USD
Low57.94 USD
Close (prev. day)58.00 USD
VWAP57.071526 USD
Volume (pcs)70,443
Trading volume4,020,412.50
Number of trades15
Last size123

Futures and Options

Related Futures106
Related Options-

PDF Downloads

Company report: KONINKLIJKE PHILIPS NVPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2021/05/05 16:53:05
Price
57.94 USD
Difference -0.10% (-0.06)

General attributes

ISINNL0000009538
SymbolPHIA
ExchangeFINRA other OTC Issues
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)43,220 EUR
BenchmarkAMSTERDAM EXCHANGES INDEX

Market data

Bid (Bid size)-
Ask (Ask size)-
Open57.94 USD
High57.94 USD
Low57.94 USD
Close (prev. day)58.00 USD
VWAP57.071526 USD
Volume (pcs)70,443
Trading volume4,020,412.50
Number of trades15
Last size123

Performance and Risk

6m1Y3Y
Perf (%)+12.83%+37.96%-
Perf (abs.)+6.59+15.94-
Beta0.810.990.90
Volatility22.8925.9126.78
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)57.52 USD (14,913)
Ø price 30 days | Ø volume 30 days (pcs.)54.76 USD (10,478)
Ø price 100 days | Ø volume 100 days (pcs.)54.70 USD (9,414)
Ø price 250 days | Ø volume 250 days (pcs.)48.05 USD (13,404)
YTD High | date61.06 USD (2021/04/15)
YTD Low | date53.75 USD (2021/03/03)
52 Weeks High | date61.06 USD (2021/04/15)
52 Weeks Low | date40.02 USD (2020/05/14)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2021/05/0609:4648.455 EUR0.1523
Vienna Stock Exchange2021/05/0609:0548.12 EUR0.001
Tradegate2021/05/0610:5347.965 EUR0.039
Stuttgart2021/05/0609:1548.24 EUR0.002
SIX Swiss Exchange2019/12/2717:3547.37 CHF0.001
Munich2021/05/0608:0347.81 EUR0.001
London Stock Exchange European Trade Reporting2021/05/0609:0047.9275 EUR0.001
Hanover2021/05/0608:3947.81 EUR0.001
Hamburg2021/05/0608:3947.81 EUR0.001
Frankfurt2021/05/0610:4047.96 EUR0.022
FINRA other OTC Issues2021/05/0516:5357.94 USD4.0215
Euronext Amsterdam2021/05/0611:4647.80 EUR24.015,529
Duesseldorf2021/05/0611:3047.765 EUR0.004
Borsa Italiana MTF Trading After Hours2020/11/1719:1144.365 EUR0.001
Borsa Italiana MTF Global Equity Market2021/05/0611:1148.005 EUR0.044
Berlin2021/05/0610:5547.945 EUR0.005

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=2324&ID_TYPE_IMAGE_LOGO=2

Contact Details

KONINKLIJKE PHILIPS NV
- -
Philips Center - 1096 BC Amsterdam
Telefon: 31-20-597-77-77
Fax: -
E-mail: -

PDF Downloads

Company report: KONINKLIJKE PHILIPS NVPDF Download

Company Profile

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Personal Health, Diagnosis & Treatment, Connected Care & Health Informatics, and Other. The Personal Health segment focuses on healthy living and preventative care. This segment comprises the Personal Care, Domestic Appliances, Oral Healthcare, and Mother & Child Care businesses. The Diagnosis & Treatment segment unites the businesses related to the promise of precision diagnosis and disease pathway selection, and the businesses related to image-guided, minimally invasive treatments. This segment comprises the Diagnostic Imaging, Ultrasound, Healthcare Informatics and Image-Guided Therapy businesses. The Connected Care & Health Informatics segment focuses on patient care solutions, advanced analytics and patient and workflow optimization inside and outside the hospital, and aims to unlock synergies from integrating and optimizing patient care pathways and leveraging provider-payer-patient business models. This segment comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, and Sleep & Respiratory Care businesses. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Members of Management Board

Frans van HoutenChairman of Managing Board
Daniela SeabrookMember of Executive Committee
Jan KimpenMember of Executive Committee
Marnix van GinnekenMember of Executive Committee
Abhijit BhattacharyaMember of Executive Committee
Aisha BarryMember of Executive Committee
Andy HoMember of Executive Committee
Bert van MeursMember of Executive Committee
Derya GuzelMember of Executive Committee
Edwin PaalvastMember of Executive Committee
Henk de JongMember of Executive Committee
Jeroen TasMember of Executive Committee
John FrankMember of Executive Committee
Karen SörensenMember of Executive Committee
Robert CascellaMember of Executive Committee
Roy JakobsMember of Executive Committee
Sean CarneyMember of Executive Committee
Sophie BechuMember of Executive Committee
Vitor RochaMember of Executive Committee

Board of directors

Jeroen van der VeerChairman of Supervisory Board
A. HarrisonMember of Supervisory Board
David PyottMember of Supervisory Board
Paulus StoffelsMember of Supervisory Board
Christine PoonMember of Supervisory Board
Feike SijbesmaMember of Supervisory Board
Mary DohertyMember of Supervisory Board
Neelam DhawanMember of Supervisory Board
Orit GadieshMember of Supervisory Board
Peter D. LöscherMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended), citizen/resident of Australia, Canada, Great Britain and Japan. For this reason, the distribution or redistribution of the information, materials and products into United States, Australia, Canada, Great Britain and Japan or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited.

The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.